Efficacy and tolerability of topiramate in childhood and adolescent epilepsy: a clinical experience

被引:38
作者
Mohamed, K [1 ]
Appleton, R [1 ]
Rosenbloom, L [1 ]
机构
[1] Alder Hey Childrens Hosp, Dept Neurol, Liverpool L12 2AP, Merseyside, England
来源
SEIZURE-EUROPEAN JOURNAL OF EPILEPSY | 2000年 / 9卷 / 02期
关键词
topiramate; children; adolescents; open study;
D O I
10.1053/seiz.2000.0387
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
A 3-year retrospective review was undertaken of the use of topiramate in 51 children aged 3-16 years with partial and generalized epilepsies who attended a tertiary referral epilepsy centre in a large children's hospital. The mean follow-up period was 19 months (range 6-33 months). Twenty-six children (51%) were still receiving topiramate at the time of their last review. Fifteen children (29%) showed a greater than 50% reduction in their seizure frequency and four children (8%) became seizure free, three on topiramate monotherapy. The drug appeared to be most effective in children with moderate learning difficulties with 75% showing an improvement in seizure control compared with 25% of children with normal educational functioning. Topiramate was withdrawn in 25 patients. The reasons for withdrawal included adverse effects in 20, lack of effect in three and worsening of seizures in two patients. Adverse side effects were reported in 57% of the 51 patients. The majority of the side effects were related to behavioural and cognitive difficulties, with less-common side effects including anorexia, weight loss and headaches. (C) 2000 BEA Trading Ltd.
引用
收藏
页码:137 / 141
页数:5
相关论文
共 11 条
[1]   Preliminary open-label experience with topiramate in primary generalized seizures [J].
Biton, V .
EPILEPSIA, 1997, 38 :S42-S44
[2]   A double-blind, randomized trial of topiramate as adjunctive therapy for partial-onset seizures in children [J].
Elterman, RD ;
Glauser, TA ;
Wyllie, E ;
Reife, R ;
Wu, SC ;
Pledger, G .
NEUROLOGY, 1999, 52 (07) :1338-1344
[3]   Topiramate use in pediatric patients [J].
Glauser, TA .
CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 1998, 25 (03) :S8-S12
[4]   Topiramate in clinical practice: first year's postlicensing experience in a specialist epilepsy clinic [J].
Kellett, MW ;
Smith, DF ;
Stockton, PA ;
Chadwick, DW .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1999, 66 (06) :759-763
[5]  
Kerr MP, 1998, J INTELL DISABIL RES, V42, P74
[6]   Acute psychotic symptoms induced by topiramate [J].
Khan, A ;
Faught, E ;
Gilliam, F ;
Kuzniecky, R .
SEIZURE-EUROPEAN JOURNAL OF EPILEPSY, 1999, 8 (04) :235-237
[7]   Topiramate for intractable childhood epilepsy [J].
Moreland, EC ;
Griesemer, DA ;
Holden, KR .
SEIZURE-EUROPEAN JOURNAL OF EPILEPSY, 1999, 8 (01) :38-40
[8]   Topiramate as adjunctive therapy in refractory partial epilepsy: Pooled analysis of data from five double-blind, placebo-controlled trials [J].
Reife, RA ;
Pledger, GW .
EPILEPSIA, 1997, 38 :S31-S33
[9]   Topiramate monotherapy for partial onset seizures [J].
Sachdeo, RC ;
Reife, RA ;
Lim, P ;
Pledger, G .
EPILEPSIA, 1997, 38 (03) :294-300
[10]   A double-blind, randomized trial of topiramate in Lennox-Gastaut syndrome [J].
Sachdeo, RC ;
Glauser, TA ;
Ritter, F ;
Reife, R ;
Lim, P ;
Pledger, G .
NEUROLOGY, 1999, 52 (09) :1882-1887